Mark D. Shepherd
Mark D. Shepherd publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Economics and Econometrics, on topics such as Diabetes Management and Research, Lipoproteins and Cardiovascular Health and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #2,353,509 of 7,710,434 ranked researchers
- Rank in United States
- #699,970 of 1,627,098
- Works
- 17
- Citations
- 1.2k
- Citations per work
- 70.6
What does Mark D. Shepherd research?
Mark D. Shepherd's work is mostly in Medicine (47%), Engineering (12%), Economics, Econometrics and Finance (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences846.6%
- Medicine846.6%
- Everything else527.7%
- Physical Sciences316.4%
- Engineering211.7%
- Chemistry14.7%
- Social Sciences29.3%
- 1Endocrinology, Diabetes and Metabolism33% of their works
- 2Surgery14% of their works
- 3Economics and Econometrics9% of their works
- 4Biomedical Engineering7% of their works
- 5Mechanical Engineering5% of their works
- 6Spectroscopy5% of their works
Research topics
- Diabetes Management and Research
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Advanced Chemical Sensor Technologies
- Gas Dynamics and Kinetic Theory
- Diabetes Management and Education
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Which keywords describe Mark D. Shepherd's research?
The keywords of their largest research topics: Diabetes, Cardiovascular Disease, Glycemic Control, Cholesterol-lowering, Hypoglycemia, Insulin Therapy, Statins and Insulin Resistance.
- Quality of Life
- Generic Drugs
- Drug Development Costs
- Cost-effectiveness Analysis
- Boltzmann Equation
- Insulin Resistance
- Insulin Therapy
- Cholesterol-lowering
- Cardiovascular Disease
- Diabetes
- Glycemic Control
- Hypoglycemia
- Statins
- Metabolic Syndrome
- Breath Analysis
- Depression
- Electronic Nose
- Kinetic Theory
- Self-Management
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Diabetes93 topics
- Cardiovascular Disease72 topics
- Glycemic Control62 topics
- Cholesterol-lowering41 topic
- Hypoglycemia41 topic
- Insulin Therapy41 topic
- Statins41 topic
- Insulin Resistance31 topic
- Metabolic Syndrome31 topic
- Boltzmann Equation21 topic
- Breath Analysis21 topic
- Cost-effectiveness Analysis21 topic
- Depression21 topic
- Drug Development Costs21 topic
- Electronic Nose21 topic
- Generic Drugs21 topic
- Kinetic Theory21 topic
- Quality of Life21 topic
- Self-Management21 topic
Where does Mark D. Shepherd work?
Mark D. Shepherd's main affiliation in the publication record is Hematology Oncology Consultants, United States.
How many publications and citations does Mark D. Shepherd have?
OpenAlex counts 17 works and 1,201 citations for Mark D. Shepherd, an h-index of 8, ranking #2,353,509 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark D. Shepherd. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.